New drug combination may shorten tuberculosis treatment, study saysBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1518 (Published 18 March 2015) Cite this as: BMJ 2015;350:h1518
- Susan Mayor
A new combination drug regimen is more effective at reducing levels of the bacterium that causes tuberculosis than standard treatment and acts more quickly, an initial short term study has found.
The study randomised 207 patients with drug susceptible pulmonary tuberculosis to receive the new combination of pretomanid (either 100 mg or 200 mg), an antibiotic with a novel mode of action against Mycobacterium tuberculosis, moxifloxacin, and …
Log in using your username and password
Log in through your institution
Sign up for a free trial